BioMed Research International / 2019 / Article / Tab 2

Research Article

Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics

Table 2

The values of noninvasive markers in patients with significant, no significant fibrosis, without and with cirrhosis.

Fibrosis  
Markers
No significant fibrosis  
(F0-F1, F1, F1-F2)   
(n=51)
Significant fibrosis  
(F≥2)   
(n=21)
Without cirrhosis  
(F0-F1, F1, F1-  
F2, F2, F3)   
(n=76)
Cirrhosis  
(F3-F4, F4)   
(n=14)

APRI1.72 ± 1.732.18 ± 2.211.80 ± 1.744.02 ± 2.84  
P1=0.254P2=0.001

Forn’s8.85 ± 1.799.83 ±1.839.12 ± 1.9211.71 ± 1.77
P1=0.063P2<0.001

FIB-44.21 ± 3.376.47 ± 6.234.64 ± 4.0110.77 ± 5.50
P1=0.131P2<0.001

GAPRI158 ± 219295 ± 300276 ± 287832 ± 652
P1=0.020P2<0.001

AP4.74 ± 2.275.57 ± 2.134.91 ± 2.236.86 ± 2.28
P1=-1.003P2=0.004

Hepascore0.39 ± 0.210.60 ± 0.280.43 ± 0.250.80 ± 0.21
P1=0.008P2<0.001

FibroTest0.32 ± 0.080.58 ± 0.080.38 ± 0.140.87 ± 0.09
P1<0.001P2<0.001

Data are presented as mean ± SD. P1: P value between significant and no significant fibrosis; P2: P value between cirrhosis and no cirrhosis; means statistically significant difference.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.